Results 51 to 60 of about 18,898 (135)

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

International Journal of Nanomedicine, 2017
Quan Qi,1,* Lei Lu,2,3,* Haiqing Li,1,* Zhize Yuan,1 Gaoxian Chen,2,3 Miao Lin,2,3 Zhengwen Ruan,4 Xiaofeng Ye,1 Zeyu Xiao,2,3,5 Qiang Zhao1 1Department of Cardiac Surgery, Rui Jin Hospital, 2Department of Pharmacology, Institute of Medical Sciences ...
Qi Q, Lu L, Li H, Yuan Z, Chen G, Lin M, Ruan Z, Ye X, Xiao Z, Zhao Q   +9 more
doaj  

The effects of liraglutide on the characteristics of blood parameters and testicular tissue induced diabetes and obesity in mice [PDF]

مجله دانشگاه علوم پزشکی بیرجند
Background and Aims: Obesity and diabetes are the most common metabolic disorders that have negative effects on organisms, including the reproductive system. The drug treatments cause fertility disorders. One of the candidate drugs is liraglutide.
Saied Mohammadzadeh, Mosayeb Amiri
doaj  

Liraglutide-Induced Acute Hepatocellular Injury With Positive Rechallenge: A Case Report and Literature Review. [PDF]

Clin Med Insights Case Rep
Adi M, Ashraf A, Eshimova S, Husanov S.
europepmc   +1 more source

Correction: Protective effects of liraglutide on hypercholesterolemia-associated atherosclerosis involve attenuation of endothelial-monocyte adhesion through down-regulating the LOX-1/NF-κB signaling pathway. [PDF]

Sci Rep
Wu A, Wu Y, Song M, Chen W, Xu K, Wu M, Lin L.   +6 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists and rotator cuff disease: a scoping review. [PDF]

BMC Musculoskelet Disord
Duru DO, Zhou AK, Lee DKR, Carroll PJ, Elmaraghy A.   +4 more
europepmc   +1 more source

Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review. [PDF]

Front Med (Lausanne)
Wu H, Zhang ZH, Ye T, Chen JN, Tung TH, Zhu JS.   +5 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists Inhibit the Initiation of Toxic Amyloid-β42 Aggregation. [PDF]

J Am Chem Soc
Fallot LB, Anderson CA, Pinc JR, Stevenson A, Schleck MC, Hawryschuk E, Li OZ, Palchak JC, Toole JR, Kubiak Ii RW, Dear AJ, Michaels TCT, Limbocker R.   +12 more
europepmc   +1 more source

Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial. [PDF]

Stroke
Lu L, Yang B, Wang Y, Zhu C, Liu Z, Li F, Yang S, Liu Y, Yang Y, Liu X, Huang L, Xu A, Zhu H.   +12 more
europepmc   +1 more source

Methyl Proton Spin Relaxation (<i>R</i>₂/<i>R</i>₁) Enables Sensitive Detection of pH-Dependent Oligomerization in GLP-1 Analogs. [PDF]

Anal Chem
Lu J, Pang E, Chen K.
europepmc   +1 more source

Roflumilast Enhances Liraglutide's Atrial Natriuretic Peptide-Dependent Suppression of Adrenal Aldosterone Secretion. [PDF]

Int J Mol Sci
Hosseini A, M'Sadoques AJ, Stoicovy RA, Altsman VL, Raynshteyn L, Weinstein E, Baggio Lopez T, Del Calvo G, Leiker MG, Lymperopoulos A.   +9 more
europepmc   +1 more source